Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Stockholders' Equity (Deficit)

v3.21.2
Unaudited Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
June 2020 notes payable, net (June 2020 Notes)
Seller Notes and ABG Notes
Series F Convertible Preferred Stock
Redeemable Series E Convertible Preferred Stock
Common Stock
Common Stock
Series F Convertible Preferred Stock
Series F Convertible Preferred Stock
Series F Convertible Preferred Stock
Additional Paid-In Capital
Additional Paid-In Capital
June 2020 notes payable, net (June 2020 Notes)
Additional Paid-In Capital
Seller Notes and ABG Notes
Additional Paid-In Capital
Series F Convertible Preferred Stock
Accumulated Deficit
Balance at Dec. 31, 2019 $ (7,071)         $ 8     $ 194,190       $ (201,269)
Balance (in shares) at Dec. 31, 2019           7,996,232              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares and warrants issued pursuant to private placement 500               500        
Shares and warrants issued pursuant to private placement (in shares)           51,440              
Share-based compensation 2,485         $ 1     2,484        
Share-based compensation (in shares)           75,993              
Shares and warrants issued to third party for contract termination 198               198        
Shares and warrants issued to third party for contract termination (in shares)           12,120              
Shares issued to third parties for services 125               125        
Stock issued to third parties for services (in shares)           20,833              
Warrants issued to third parties for services 2,594               2,594        
Net and comprehensive loss available to common stockholders (9,488)                       (9,488)
Balance at Mar. 31, 2020 (10,657)         $ 9     200,091       (210,757)
Balance (in shares) at Mar. 31, 2020           8,156,618              
Balance at Dec. 31, 2019         $ 10,566                
Balance (in shares) at Dec. 31, 2019         1,387,378                
Balance at Mar. 31, 2020         $ 10,566                
Balance (in shares) at Mar. 31, 2020         1,387,378                
Balance at Dec. 31, 2019 (7,071)         $ 8     194,190       (201,269)
Balance (in shares) at Dec. 31, 2019           7,996,232              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net and comprehensive loss available to common stockholders (27,926)                        
Balance at Jun. 30, 2020 (16,614)         $ 9     212,572       (229,195)
Balance (in shares) at Jun. 30, 2020           8,156,618              
Balance at Dec. 31, 2019         $ 10,566                
Balance (in shares) at Dec. 31, 2019         1,387,378                
Balance at Jun. 30, 2020         $ 10,566                
Balance (in shares) at Jun. 30, 2020         1,387,378                
Balance at Mar. 31, 2020 (10,657)         $ 9     200,091       (210,757)
Balance (in shares) at Mar. 31, 2020           8,156,618              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Share-based compensation 3,020               3,020        
Warrants issued to third parties for services 7,390               7,390        
Warrants issued in connection with June 2020 Notes 337               337        
Beneficial conversion feature of June 2020 Notes   $ 1,163               $ 1,163      
Modification of conversion feature for November 2019 Notes, Seller Notes, and ABG Notes     $ 528               $ 528    
Modification of warrants 43               43        
Net and comprehensive loss available to common stockholders (18,438)                       (18,438)
Balance at Jun. 30, 2020 (16,614)         $ 9     212,572       (229,195)
Balance (in shares) at Jun. 30, 2020           8,156,618              
Balance at Mar. 31, 2020         $ 10,566                
Balance (in shares) at Mar. 31, 2020         1,387,378                
Balance at Jun. 30, 2020         $ 10,566                
Balance (in shares) at Jun. 30, 2020         1,387,378                
Balance at Dec. 31, 2020 (28,102)         $ 9   $ 0 232,530       (260,641)
Balance (in shares) at Dec. 31, 2020           8,651,400   21,754          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Shares and warrants issued pursuant to private placement 4,072         $ 1     4,071        
Shares and warrants issued pursuant to private placement (in shares)           546,733              
Share-based compensation 2,544               2,544        
Share-based compensation (in shares)           17,537              
Warrant exercises 1,310               1,310        
Warrant exercises (in shares)           297,383              
Shares issued to third parties for services 46               46        
Stock issued to third parties for services (in shares)           5,000              
Warrant modifications 0               402       (402)
Conversion of Series F shares to common stock       $ 0     $ 1         $ (1)  
Conversion of Series F shares to common stock (in shares)             1,482,672 (4,448)          
Net and comprehensive loss available to common stockholders (12,850)                       (12,850)
Balance at Mar. 31, 2021 (32,980)         $ 11   $ 0 240,902       (273,893)
Balance (in shares) at Mar. 31, 2021           11,000,725   17,306          
Balance at Dec. 31, 2020 (28,102)         $ 9   $ 0 232,530       (260,641)
Balance (in shares) at Dec. 31, 2020           8,651,400   21,754          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net and comprehensive loss available to common stockholders 11,926                        
Balance at Jun. 30, 2021 14,260         $ 16   $ 0 263,361       (249,117)
Balance (in shares) at Jun. 30, 2021           15,821,559   17,294          
Balance at Mar. 31, 2021 (32,980)         $ 11   $ 0 240,902       (273,893)
Balance (in shares) at Mar. 31, 2021           11,000,725   17,306          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Share-based compensation 313               313        
Warrant exercises 375               375        
Warrant exercises (in shares)           83,333              
Conversion of Series F shares to common stock (in shares)             4,000 (12)          
Conversion of convertible notes to common stock (in shares)           4,732,420              
Conversion of convertible notes to common stock 21,776         $ 5     21,771        
Stock issued in lieu of fractional shares, reverse stock split           1,081              
Net and comprehensive loss available to common stockholders 24,776                       24,776
Balance at Jun. 30, 2021 $ 14,260         $ 16   $ 0 $ 263,361       $ (249,117)
Balance (in shares) at Jun. 30, 2021           15,821,559   17,294